Related Experiment Video

Updated: Jun 19, 2026

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

Gene-directed enzyme prodrug therapy for cancer: a glimpse into the future?

Gerald W Both1

  • 1Biotech Equity Partners, North Ryde, NSW, 2113, Australia.

Discovery Medicine
|October 17, 2009
PubMed

Insights

Gene-directed enzyme prodrug therapy is a novel cancer treatment. Clinical trials for brain and prostate cancers are complete, with a brain tumor therapy nearing approval, signaling advancements in gene medicine.

Area of Science:

  • Oncology
  • Gene Therapy
  • Pharmacology

Background:

  • Gene-directed enzyme prodrug therapy (GDEPT) presents a promising strategy for cancer treatment.
  • GDEPT utilizes genetic modification to enhance the efficacy of prodrugs, targeting cancer cells specifically.
  • This approach aims to minimize systemic toxicity associated with conventional chemotherapy.

Purpose of the Study:

  • To review the current status and future potential of gene-directed enzyme prodrug therapy.
  • To highlight key innovations and clinical advancements in the field.
  • To discuss the therapeutic implications for various cancer types.

Main Methods:

  • Review of clinical trial data for GDEPT in brain and prostate cancers.
  • Analysis of recent technological innovations in gene medicine delivery and enzyme-prodrug systems.
  • Assessment of regulatory progress for GDEPT-based therapeutics.

Main Results:

  • Successful completion of clinical trials for brain and prostate cancers.
  • A GDEPT product for post-surgical brain tumor treatment is pending marketing approval.
  • Emerging innovations suggest significant future potential for GDEPT.

Conclusions:

  • Gene-directed enzyme prodrug therapy has demonstrated clinical efficacy and is progressing towards market approval.
  • Ongoing innovations in gene medicine are poised to expand the applications of GDEPT.
  • This therapeutic modality represents a significant advancement in targeted cancer treatment.

More Related Videos

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.